Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Bank of America data show 53% of large-cap active funds outperformed their Russell benchmarks in June. For the first half of the year, 38% of large-cap active funds beat benchmarks, matching the long-term annual average and rising from 29% in 2025. Performance varied by style and market cap, with growth strategies and small- and mid-cap funds posti…
PVH sold off after a regional slowdown hit guidance. The business still generates strong free cash flow, trades at low multiples, and carries modest leverage. If geopolitical pressures in EMEA ease, PVH offers asymmetric upside from current levels with defined risk controls.
U.S. hedge funds reduced exposure to technology hardware, including semiconductor stocks, for a fourth straight week, Goldman Sachs said in a client note. The selling comes alongside a 4.2% weekly drop in the SOX semiconductor index through July 3 and as investors weigh heavy AI-related spending against uncertain timing for returns.
Meta Platforms rose 1.4% in pre-market trading after CEO Mark Zuckerberg told employees that development of the company’s AI agents has not accelerated as expected, while reiterating confidence that meaningful returns from AI investments should begin within three to six months. Investor enthusiasm for a potential cloud business to monetize excess A…
Kyverna's registrational SPS data validated miv-cel's mechanism and cleared the first commercial hurdle. The market still prices the company like a single-indication biotech. With a market cap near $540M, low net leverage, and a deep autoimmune pipeline (gMG, lupus nephritis), KYTX offers a compelling asymmetric risk/reward for an event-driven long…
Ondas Inc. said it will buy DZYNE Technologies for $875.8 million in a transaction made up of cash and stock. The purchase reorients Ondas toward a full-service autonomous defense technology platform and increases its 2026 revenue target following another recent acquisition. DZYNE brings unmanned aircraft, smaller drones and counter-drone systems t…
ZIM Integrated Shipping Services stock dropped 6.8% following public statements from Israeli officials opposing the carrier's proposed sale to Hapag-Lloyd. Senior cabinet members and the defense ministry stated the transaction, as presented, does not sufficiently safeguard Israel's security interests. Officials also noted the government retains a "…
Thales and Leonardo led a consortium selected by the NATO Communications and Information Agency to supply secure, deployable communications systems for the alliance's special forces. Both firms' shares rose in European trading following the award. The contract will deliver six Deployable Points of Presence for Special Operations Component Commands …
Seer, Inc. (NASDAQ:SEER) saw its stock surge 30% on Monday after filing an investor presentation with the SEC that outlined commercial progress, market opportunity, and recent cost reductions. The filing, made ahead of the company's July 28, 2026 annual meeting, also came amid an active proxy contest.
Strategy Inc. shares climbed in pre-open trading after the company's board approved a framework allowing selective monetization of up to $1.25 billion in Bitcoin to bolster liquidity, support preferred dividends and fund repurchases. Cantor Fitzgerald reiterated an Overweight rating and a $212 target after talks with Executive Chairman Michael Sayl…
Compass Pathways Plc shares rose in pre-market trade as the company approaches the COMP006 Phase 3 26-week durability readout, which management had guided for early Q3 2026. The data is viewed as the last significant clinical milestone before a planned Q4 2026 New Drug Application filing for COMP360 in treatment-resistant depression. Analyst upgrad…
Keel Infrastructure Corp., a North American digital infrastructure and energy company, has appointed Ganesh Aiyer as President. Aiyer brings significant expertise from Digital Realty Trust and other major tech companies, positioning Keel for long-term growth by expanding its commercial operations and power infrastructure development in high-demand …
Scilex Holding Company said it has signed a binding term sheet for a proposed $100 million strategic investment from iHolding Group LLP. The transaction would see iHolding buy newly issued Scilex common shares at $15.00 per share, subject to due diligence and customary approvals. The announcement sent Scilex stock higher by 7% on Monday.
Memory and storage equities climbed in premarket trading as several broker notes raised pricing and revenue forecasts and highlighted sustained AI-driven demand. UBS upgraded its DDR contract pricing outlook and warned of a prolonged DRAM undersupply; Citi placed Micron on an upside 90-day catalyst watch with higher ASP growth estimates; Bank of Am…
Volkswagen CEO Oliver Blume must persuade the carmaker’s supervisory board to approve a plan that would deepen cost cuts through four proposed plant closures and roughly 50,000 additional job losses, a move that has drawn strong resistance from unions and key shareholders and could determine the direction of the group.
Prospect Capital Corporation has completed a first lien senior secured term loan and equity-linked investment in ShipOffers, a leading on-demand product and order fulfillment company. This investment aims to support ShipOffers' growth through expansion of people, technology, and facilities, enhancing its ability to serve e-commerce and direct-to-co…
Invivyd announced receipt of a formal twelve-month advance notice from the FDA that the Emergency Use Authorization (EUA) for its COVID-19 monoclonal antibody treatment PEMGARDA will terminate on June 29, 2027, following the Department of Health and Human Services' planned end to the COVID-19 EUA declaration. Invivyd is engaging with FDA on next re…
Quantum Cyber N.V. responded to a recent short-seller report which it claims contains misleading information on its capital structure, business strategy, and technology partnerships. The Company emphasized full disclosure in its SEC filings, outlined its autonomous defense technology initiatives including patent filings, addressed its relationship …
VERAXA Biotech AG has provided a mid-2026 business update highlighting substantial progress in developing its novel BiTAC® technology and pipeline, focusing on BiTAC T cell engagers for solid tumors. The company aims to have an IND/CTA-ready candidate by early 2028 while planning to monetize non-BiTAC assets to finance growth. Ongoing industry inte…
Opus Genetics announced FDA alignment on the Phase 3 registrational trial design for their gene therapy OPGx-LCA5 targeting LCA5-associated inherited retinal disease, an ultra-rare form of childhood blindness. The FDA permits a Biologics License Application submission based on six-month efficacy data, with durability data at 12 months to complete t…
NN, Inc. announced a significant milestone in its Medical Products business by becoming qualified and receiving initial purchase orders to manufacture critical components for a leading robotic-assisted surgery platform. This breakthrough is part of NN's targeted growth strategy in medical markets and adds approximately $25 million to its medical ne…
Wrap Technologies announced that the ATF has issued a ruling formally classifying its BolaWrap 150 device as an instrument of restraint rather than a firearm or weapon under federal law. This classification removes regulatory uncertainty, potentially streamlining procurement processes and expanding accessible markets across corrections, civilian sa…
Seer, Inc. filed an investor presentation emphasizing its leadership in deep proteomics technology with significant commercial potential and advancing AI-driven precision medicine. The company reports strong growth metrics, a robust innovation pipeline, cost discipline, and a highly qualified, independent board urging stockholders to support its di…
Belite Bio, a clinical-stage biotech company, announced that data from its Phase 3 DRAGON trial of Tinlarebant, an oral therapy targeting retinal degenerative diseases, will be presented at upcoming international medical conferences. Tinlarebant aims to treat Stargardt Disease by reducing toxic vitamin A derivatives in the eye. The drug has receive…
Aurora Mobile Limited (NASDAQ: JG) has partnered with Pobo Financial to implement its JPush intelligent push notification technology across Pobo Financial's mobile apps. This collaboration aims to improve the timeliness, reliability, and stability of delivering critical financial information and alerts, especially for derivatives market investors w…
